Skip to main content

Resources

Explore our growing body of resources and research from across the women’s health innovation ecosystem.

Explore

    2007

    Academic Journal Article
    Endometriosis
    Female-Specific Conditions
    North America

    Endometriosis: Cost Estimates and Methodological Perspective

    Simoens, S. et al.

    Reviews data on cost estimates and methodologies for quantifying the economic impact of endometriosis, highlighting gaps and needs for improved research.

    Endowed Chairs And Professorships: A New Frontier In Gender Equity

    2022

    Academic Journal Article
    Report (Non-Academic)
    Training and Careers
    North America

    Endowed Chairs And Professorships: A New Frontier In Gender Equity

    Thorndyke, L. E. et al.

    Provides data on gender distribution of endowed positions at U.S. medical schools and reviews strategies to promote women’s representation and equity in academic medicine.

    Equity 2030 Alliance: Collective Impact Report 2024 and Beyond

    2024

    Report (Non-Academic)
    Ecosystem Progress
    Africa
    Asia-Pacific
    Europe
    Global
    Latin America & Caribbean
    Middle East
    North America

    Equity 2030 Alliance: Collective Impact Report 2024 and Beyond

    Equity 2030 Alliance

    Summarizes collective actions, investments, data, and outcomes advancing gender equity in science, technology, and finance to inform and inspire global change.

    Erlotinib Versus Chemotherapy as First-Line Treatment for Patients with Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer (Optimal, Ctong-0802): A Multicentre, Open-Label, Randomised, Phase 3 Study

    2011

    Academic Journal Article
    Cancer
    Cancer, Lung
    Non-Communicable and Chronic Conditions
    Asia-Pacific

    Erlotinib Versus Chemotherapy as First-Line Treatment for Patients with Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer (Optimal, Ctong-0802): A Multicentre, Open-Label, Randomised, Phase 3 Study

    Zhou, C. et al.

    Reviews data on the efficacy and safety of pazopanib in advanced renal-cell carcinoma, supporting its use as a first-line treatment option.

    European VC Female Founders Dashboard

    2023

    Dashboards and Data Visualization
    Innovation Introduction
    Europe

    European VC Female Founders Dashboard

    PitchBook

    Provides information on European venture capital investment trends for female-founded startups since 2008, using interactive data sourced from the PitchBook platform.

    Evaluation of Drug Labels Following the 2015 Pregnancy and Lactation Labeling Rule

    2020

    Academic Journal Article
    Pregnancy & Fertility
    Female-Specific Conditions
    North America

    Evaluation of Drug Labels Following the 2015 Pregnancy and Lactation Labeling Rule

    Byrne, J. J. et al.

    Reviews compliance of new drug labels with the 2015 Pregnancy and Lactation Labeling Rule and summarizes available pregnancy and lactation data sources for regulatory evaluation.

    Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex

    2024

    Academic Journal Article
    Migraine
    Non-Communicable and Chronic Conditions
    North America

    Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex

    Porreca et al.

    Summarizes sex-specific outcomes of CGRP-targeting therapies for acute and preventive migraine treatment, highlighting differences in efficacy between men and women.

    Exploring the Experience of Pain and Pain Management for Pregnant and Postpartum Veterans with Chronic Musculoskeletal Pain

    2024

    Academic Journal Article
    Chronic Pain
    Non-Communicable and Chronic Conditions
    North America

    Exploring the Experience of Pain and Pain Management for Pregnant and Postpartum Veterans with Chronic Musculoskeletal Pain

    Kroll-Desrosiers

    Summarizes experiences, barriers, and recommendations for pain management among pregnant and postpartum veterans with chronic musculoskeletal pain to inform improved VHA care.

    Federal Legislative Agenda 2023-2024

    2023

    Report (Non-Academic)
    Cross-Sector Partnership
    North America

    Federal Legislative Agenda 2023-2024

    Society for Women's Health Research

    Summarizes SWHR’s 2023-2024 federal legislative priorities and policy recommendations to advance women’s health research, equity, and access.

    FemTech Landscape 2023

    2024

    Report (Non-Academic)
    Menopause
    Vaginal Microbiome
    Ecosystem Progress
    Asia-Pacific
    Europe
    Global
    Middle East
    North America

    FemTech Landscape 2023

     FemHealth Insights

    Provides information on FemTech industry trends, startup data, investments, exits, organizations, and predictions to inform stakeholders about the evolving women's health technology landscape.

    Fifth Anniversary Of The Sex And Gender Equity In Research (SAGER) Guidelines: Taking Stock And Looking Ahead

    2021

    Academic Journal Article
    Research Design and Methodologies
    Asia-Pacific
    Europe
    Global
    North America

    Fifth Anniversary Of The Sex And Gender Equity In Research (SAGER) Guidelines: Taking Stock And Looking Ahead

    Peters, S. A. E. et al.

    Summarizes the SAGER guidelines’ role, barriers to implementation, and recommendations for improving sex and gender equity in health research reporting.

    2024

    Academic Journal Article
    Social and Structural Determinants
    Africa
    Asia-Pacific
    Global
    Latin America & Caribbean
    Middle East

    Financing for equity for women’s, children’s and adolescents’ health in low- and middle-income countries: A scoping review

    Bou-Karroum et al.

    Summarizes financing interventions and evidence to improve equity in women's, children's, and adolescents' health in low- and middle-income countries.

Funding Opportunities

Curated global opportunities relevant to women’s health outcomes. 

This list is not meant to be comprehensive — reach out if you are aware of relevant opportunities we should add. Updated every two weeks.

Within 30 days Within 90 days 90+ days away Rolling / periodic
Funder Opportunity Type Focus Deadline
Loading opportunities...
Contact Us
Have a question, partnership idea, or specific request?

We’d love to hear from you.

Contact Us
Name